Publicaciones en las que colabora con Pablo Dominguez Erquicea (11)

2022

  1. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  2. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342

2021

  1. Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation

    International Journal of Cardiology, Vol. 327, pp. 217-222

  2. Predictors of Inappropriate Dosing of Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association

  3. Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry

    Journal of Geriatric Cardiology, Vol. 18, Núm. 10, pp. 809-815

2020

  1. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 877-884

  2. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 22, Núm. 6, pp. 878-887

  3. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 21, Núm. 3, pp. 367-373.e1

2019

  1. Incidence, predictors and prognosis of new-onset cancer after hospital discharge for acute coronary syndrome

    REC: CardioClinics, Vol. 54, Núm. 3, pp. 148-156

  2. Incidence, predictors and prognosis of new-onset cancer after hospital discharge for acute coronary syndrome

    REC: CardioClinics, Vol. 54, Núm. 3, pp. 148-156

  3. Renin–Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 5, pp. 487-495